Employees: 03 (2023.0)Legal category: 5785Size: PMECreation date: 2005-08-22 (20 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: PARIS (75016), Paris
GRANDE PHARMACIE DOUMER PASSY : revenue, balance sheet and financial ratios
GRANDE PHARMACIE DOUMER PASSY is a French company
founded 20 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in PARIS (75016),
this company of category PME
shows in 2019 a revenue of 3.6 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - GRANDE PHARMACIE DOUMER PASSY (SIREN 483897484)
Indicator
2023
2022
2019
2018
2017
2016
Revenue
N/C
N/C
3 612 062 €
3 594 953 €
3 269 890 €
3 261 655 €
Net income
124 344 €
253 045 €
50 955 €
116 623 €
111 931 €
112 409 €
EBITDA
N/C
N/C
69 898 €
153 205 €
146 207 €
169 247 €
Net margin
N/C
N/C
1.4%
3.2%
3.4%
3.4%
Revenue and income statement
In 2023, GRANDE PHARMACIE DOUMER PASSY generates positive net income of 124 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2023: 112 k€ -> 124 k€.
Net income (2023)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
124 344 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 5%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 76%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2023)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
5.26%
Financial autonomy (2023)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
75.852%
Asset age ratio (2023)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution GRANDE PHARMACIE DOUMER PASSY
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2022
2023
Debt ratio
45.659
35.402
26.759
20.987
8.348
5.26
Financial autonomy
54.966
57.957
64.021
66.144
73.07
75.852
Repayment capacity
4.222
3.624
2.838
4.581
None
None
Cash flow / Revenue
3.699%
3.667%
3.526%
1.763%
None%
None%
Sector positioning
Debt ratio
5.262023
2019
2022
2023
Q1: 20.09
Med: 66.92
Q3: 169.24
Excellent
In 2023, the debt ratio of GRANDE PHARMACIE DOUMER P... (5.26) ranks in the bottom 25% of the sector, which is positive. This ratio measures the weight of debt relative to equity. A low ratio indicates a solid financial structure with little dependence on creditors.
Financial autonomy
75.85%2023
2019
2022
2023
Q1: 28.72%
Med: 48.51%
Q3: 68.17%
Excellent
In 2023, the financial autonomy of GRANDE PHARMACIE DOUMER P... (75.8%) ranks in the top 25% of the sector. This ratio represents the share of equity in total financing. High autonomy reflects financial independence and ability to absorb shocks.
Repayment capacity
4.58 years2019
2019
Q1: 1.73 years
Med: 5.0 years
Q3: 9.48 years
Good
In 2019, the repayment capacity of GRANDE PHARMACIE DOUMER P... (4.58) ranks below the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. This controlled position reflects prudent management.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 157.05. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2023)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
157.053
Liquidity indicators evolution GRANDE PHARMACIE DOUMER PASSY
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2016
2017
2018
2019
2022
2023
Liquidity ratio
119.131
128.156
141.66
133.304
154.866
157.053
Interest coverage
6.945
5.961
5.328
12.357
None
None
Sector positioning
Liquidity ratio
157.052023
2019
2022
2023
Q1: 135.23
Med: 189.76
Q3: 270.17
Average
In 2023, the liquidity ratio of GRANDE PHARMACIE DOUMER P... (157.05) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.
Interest coverage
12.36x2019
2019
Q1: 1.36x
Med: 5.41x
Q3: 11.35x
Excellent
In 2019, the interest coverage of GRANDE PHARMACIE DOUMER P... (12.4x) ranks in the top 25% of the sector. This ratio indicates how many times operating income covers interest expenses. High coverage means financial charges weigh little on profitability.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2023)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2023)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2023)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2023)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution GRANDE PHARMACIE DOUMER PASSY
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2022
2023
Operating WCR
248 995 €
320 024 €
391 347 €
520 679 €
0 €
0 €
Inventory turnover (days)
30
34
35
39
0
0
Customer payment term (days)
3
6
6
8
0
0
Supplier payment term (days)
41
47
38
41
0
0
Positioning of GRANDE PHARMACIE DOUMER PASSY in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 220 transactions of similar company sales
in 2023,
the value of GRANDE PHARMACIE DOUMER PASSY is estimated at
1 467 194 €
(range 892 270€ - 2 062 545€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2023
220 transactions
892k€1467k€2062k€
1 467 194 €Range: 892 270€ - 2 062 545€
NAF 5 année 2023
Valuation method used
Net Income Multiple
124 344 €
×
11.8x
=1 467 194 €
Range: 892 271€ - 2 062 546€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 220 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare GRANDE PHARMACIE DOUMER PASSY with other companies in the same sector:
Frequently asked questions about GRANDE PHARMACIE DOUMER PASSY
What is the revenue of GRANDE PHARMACIE DOUMER PASSY ?
The revenue of GRANDE PHARMACIE DOUMER PASSY in 2019 is 3.6 M€.
Is GRANDE PHARMACIE DOUMER PASSY profitable?
Yes, GRANDE PHARMACIE DOUMER PASSY generated a net profit of 124 k€ in 2023.
Where is the headquarters of GRANDE PHARMACIE DOUMER PASSY ?
The headquarters of GRANDE PHARMACIE DOUMER PASSY is located in PARIS (75016), in the department Paris.
Where to find the tax return of GRANDE PHARMACIE DOUMER PASSY ?
The tax return of GRANDE PHARMACIE DOUMER PASSY is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does GRANDE PHARMACIE DOUMER PASSY operate?
GRANDE PHARMACIE DOUMER PASSY operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart